We are excited to announce the upcoming Endure4Eden fundraiser, organized by Philip Robertson and his team, to support the Phelan-McDermid Syndrome Foundation. Taking place on
We have breaking news! Jaguar Gene Therapy has received approval from the FDA to conduct a gene therapy clinical trial in Phelan-McDermid syndrome.
This is a major milestone for our community and for drug development in Phelan-McDermid syndrome! This will be the first trial aiming to target genetic underpinnings of Phelan-McDermid syndrome.
*last updated on 3/4/2026* Profiling Responses and Immune Signatures in SHANK3-Mediated Neuropsychiatric Disease (PRISM) *This study is supported by the 2025 Shannon O’Boyle Memorial Neuropsychiatric
Over the past decade, more than 59,000 PHELAN LUCKY shirts have found homes in 33 countries across the globe. This has not only significantly increased awareness for
A large percentage (~75-80%) of people with a Phelan-McDermid syndrome diagnosis also have a diagnosis of autism spectrum disorder. This article explains why these two
by: Ronni Blumenthal, Phelan-McDermid Syndrome Foundation CEO. Save the Date for the 2024 Phelan-McDermid Syndrome Foundation International Family Conference We are so excited to announce
PMSF announced a research grants program in January 2023 to provide funding to highly motivated scientists studying Phelan-McDermid syndrome. Our goal is to accelerate exciting